• 2865 Citations
  • 31 h-Index
20012019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Francesca Vannini is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 38 Similar Profiles
Ankle Medicine & Life Sciences
Talus Medicine & Life Sciences
Cartilage Medicine & Life Sciences
Chondrocytes Medicine & Life Sciences
Allografts Medicine & Life Sciences
Foot Medicine & Life Sciences
Knee Medicine & Life Sciences
Ankle Joint Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2001 2019

  • 2865 Citations
  • 31 h-Index
  • 91 Article
  • 7 Chapter
  • 3 Review article

High Rate of Failure After Matrix-Assisted Autologous Chondrocyte Transplantation in Osteoarthritic Knees at 15 Years of Follow-up

Andriolo, L., Reale, D., Di Martino, A., Zaffagnini, S., Vannini, F., Ferruzzi, A. & Filardo, G., Jun 18 2019, In : American Journal of Sports Medicine. 47, 9, p. 2116-2122 7 p.

Research output: Contribution to journalArticle

Autologous Transplantation
Chondrocytes
Knee
Cartilage
Documentation

Phase I studies: a test bench for Italian clinical research

Cagnazzo, C., Nanni, O., Arizio, F., Franchina, V., Cenna, R., Tabaro, G., Vannini, F., Procopio, G., Gori, S. & Di Costanzo, A., Jan 1 2019, (Accepted/In press) In : Tumori.

Research output: Contribution to journalArticle

Physician Executives
Italy
Personnel Management
Research
Medical Oncology
Athletic Injuries
Athletes
Cartilage
Sports
Chondrocytes
2 Citations (Scopus)

Osteochondral Allograft: Proceedings of the International Consensus Meeting on Cartilage Repair of the Ankle

the International Consensus Group on Cartilage Repair of the Ankle, Jul 1 2018, In : Foot and Ankle International. 39, 1_suppl, p. 35S-40S 6 p.

Research output: Contribution to journalArticle

Ankle
Cartilage
Allografts
Practice Guidelines
Talus

TRIPLETE: A randomised phase III study of modified FOLFOXIRI plus panitumumab versus mFOLFOX6 plus panitumumab as initial therapy for patients with unresectable RAS and BRAF wild-type metastatic colorectal cancer

Borelli, B., Moretto, R., Lonardi, S., Bonetti, A., Antoniotti, C., Pietrantonio, F., Masi, G., Burgio, V., Marmorino, F., Salvatore, L., Rossini, D., Zaniboni, A., Zucchelli, G., Martignetti, A., Di Battista, M., Pella, N., Passardi, A., Boccaccino, A., Leone, F., Colombo, C. & 10 others, Granetto, C., Vannini, F., Marsico, V. A., Martinelli, E., Antonuzzo, L., Vitello, S., Delliponti, L., Boni, L., Cremolini, C. & Falcone, A., 2018, In : ESMO Open. 3, 4

Research output: Contribution to journalArticle